Why Women Are Wasting Money on Peptides When the Fix Is Free

Sims places sleep as the number one lever for change. She references a recent study (two weeks prior) showing that during sleep, the brain cleans itself by flushing cerebrospinal fluid (CSF) through neural tissue. When you are sleep-deprived, this cleaning process intrudes into waking hours, causing moments of lost focus and attention—essentially, daytime brain fog. By prioritizing sleep hygiene, you can shift that cleaning back to its proper sleep window, which is critical for cognitive function and for enabling all other health interventions. She sees sleep as the non-negotiable foundation upon which everything else is built, including the ability to implement the other practices she recommends.

Sims pairs this morning practice with sleep as the two bookends of a high-functioning day. She suggests that by getting up earlier than everyone else and going outside in silence, you can observe what's happening (implicitly nature, the light, the quiet) and allow yourself to settle into a more relaxed state. This isn't a one-off meditation; it's designed to be a reference point. Throughout the day, whenever stress or anxiety spikes, you can mentally return to that feeling of calm silence, thereby 'bookending' the day: start with parasympathetic activation, and end by focusing on protective sleep. She frames these two practices as the entry point to then working on other health pillars.

Sims frames this protocol as the evidence-based alternative to peptides. Instead of injecting BPC 157 or similar compounds, which lack human data, women should directly address the physiological changes that occur with declining estrogen and progesterone: a loss of muscle strength and a decrease in the stiffness of tendons (changing their tension response). This leads to overuse injuries like plantar fascia problems and hamstring tendinopathies. Her solution is to specifically strengthen the calves (which play a key role in loading the ankle and foot), work the entire posterior chain (hamstrings, glutes, back), and introduce ballistic movements such as jumps and bounds. She acknowledges the common fear around impact exercise but insists it is critical for stimulating the tissues to adapt and become more robust. She also mentions that mobilization work and blood flow restriction therapy are additional non-peptide tools, placing them in the same arsenal against soft tissue decline.

Sims points out that many compounds being promoted—peptides, NAD, methylene blue, rapamycin—lack robust human data. For BPC 157 specifically, WADA has banned it, but that doesn't constitute proof of efficacy for soft tissue injuries. She argues the real driver of plantar fascia issues, hamstring tendinopathies, and other soft tissue problems in women in their mid-30s to mid-50s isn't a deficiency that peptides fix, but rather hormonal changes that reduce muscle strength and alter tendon tension responses. Instead of expensive injections, women should redirect their effort toward targeted strength work (especially calf strength and posterior chain) and overcome the fear of plyometric exercises, which are essential for maintaining tissue health. She acknowledges that other non-pharmacological options like mobilization and blood flow restriction therapy can also be used, but the message is clear: training trumps peptides.